Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)

被引：0
|
作者：
Ghosh, Arnab [1 ]
Nagel, Katherine [1 ]
Hosszu, Kinga [1 ]
Datta, Ambika [1 ]
Thompson, Christina [1 ]
Levia, Khayla [1 ]
Kamrowski, Alyssa [1 ]
McAvoy, Devin [1 ]
Chung, David [2 ]
Landau, Heather [2 ]
Scordo, Michael [1 ]
Giralt, Sergio [1 ]
Shah, Gunjan [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant & Cellular Therapy, New York, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-260
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [41] Predictors of Response in Patients Receiving CD34-Selected Stem Cell Infusions without Conditioning to Correct Graft Failure Following Allogeneic Stem Cell Transplantation
    Cuadrado, Maria del Mar
    Lowdell, Mark W.
    Ings, Stuart
    Watts, Michael J.
    Szydlo, Richard
    Anthias, Chloe
    Madrigal, J. Alejandro
    Kottaridis, Panagiotis
    Carpenter, Ben
    Hough, Rachael
    Peggs, Karl
    Thomson, Kirsty
    Morris, Emma
    Chakraverty, Ronjon
    BLOOD, 2018, 132
  • [42] CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease
    Hemalatha G. Rangarajan
    Sara A. Crowell
    Alison S. Towerman
    Shalini S. Shenoy
    Bone Marrow Transplantation, 2022, 57 : 1592 - 1594
  • [43] NOVEL IMMUNOMODULATING AGENTS AND MONOCLONAL ANTIBODIES IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    De Marchi, R.
    Colasante, F.
    Perali, G.
    Lazzarotto, D.
    Sperotto, A.
    Cerno, M.
    Patriarca, F.
    Fanin, R.
    HAEMATOLOGICA, 2017, 102 : 169 - 169
  • [44] Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma
    MA Gertz
    MQ Lacy
    DJ Inwards
    DA Gastineau
    A Tefferi
    MG Chen
    TE Witzig
    PR Greipp
    MR Litzow
    Bone Marrow Transplantation, 2000, 26 : 45 - 50
  • [45] Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma
    Gertz, MA
    Lacy, MQ
    Inwards, DJ
    Gastineau, DA
    Tefferi, A
    Chen, MG
    Witzig, TE
    Greipp, PR
    Litzow, MR
    BONE MARROW TRANSPLANTATION, 2000, 26 (01) : 45 - 50
  • [46] Megadose CD34-selected haplocompatible donor stem cell transplantation in children.
    Sleight, Barbara S.
    Cowan, Morton J.
    Horn, Biljana
    Jaroscak, Jennifer
    McGuirk, Joseph
    Gilman, Andrew
    BLOOD, 2006, 108 (11) : 448B - 449B
  • [47] Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
    Shahzad, Moazzam
    Siddiqui, Raheel S.
    Anwar, Iqra
    Chaudhary, Sibgha Gull
    Ali, Tayyaba
    Naseem, Masooma
    Ahmed, Tehniat F.
    Ahmed, Zahoor
    Khurana, Sharad
    Ahmed, Nausheen
    Balusu, Ramesh
    Singh, Anurag K.
    Hematti, Peiman
    Callander, Natalie S.
    Abhyankar, Sunil H.
    McGuirk, Joseph P.
    Mushtaq, Muhammad Umair
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 877.e1 - 877.e8
  • [48] Second allogeneic stem cell transplantation for relapse after allografting in multiple myeloma using CD 34+ selected donor cells without immunosuppression
    Polona Novak
    Evgeny Klyuchnikov
    Ute-Marie von Pein
    Martina Güllstorf
    Maximilian Christopeit
    Francis Ayuk
    Maria Geffken
    Christine Wolschke
    Nicolaus Kröger
    Bone Marrow Transplantation, 2020, 55 : 1817 - 1820
  • [49] Outcome Predictors in CD34 Selected Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma
    Bryant, Adam
    Hilden, Patrick
    Maloy, Molly
    Perales, Miguel-Angel
    Koehne, Guenther
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S304 - S305
  • [50] Second allogeneic stem cell transplantation for relapse after allografting in multiple myeloma using CD 34+selected donor cells without immunosuppression
    Novak, Polona
    Klyuchnikov, Evgeny
    von Pein, Ute-Marie
    Guellstorf, Martina
    Christopeit, Maximilian
    Ayuk, Francis
    Geffken, Maria
    Wolschke, Christine
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2020, 55 (09) : 1817 - 1820
12345